| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/30/2011 | EP2301571A1 Tetravalent meningococcal vaccine with enhanced immunogenicity |
| 03/30/2011 | EP2301570A1 Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated and conjugated antibodies, antibody combinations and fusion proteins |
| 03/30/2011 | EP2301569A2 Vaccine and method for treatment of neurodegenerative diseases |
| 03/30/2011 | EP2301568A1 Antibody against IRTA2 for the treatment of tumour of hematopoietic origin |
| 03/30/2011 | EP2301567A1 Selective immune down regulation (SIDR) for transplantation |
| 03/30/2011 | EP2301566A1 DNA vaccines encoding heat shock proteins |
| 03/30/2011 | EP2301553A1 Polynucleotide therapy |
| 03/30/2011 | EP2301552A1 Polynucleotide therapy |
| 03/30/2011 | EP2301535A1 Immunological uses of immunomodulatory compounds for vaccine and anti-infectious disease therapy |
| 03/30/2011 | EP2301356A2 Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors |
| 03/30/2011 | EP2300609A1 Novel immunoadjuvant flagellin-based compounds and use thereof |
| 03/30/2011 | EP2300499A1 Anti-prion protein antibody fragment |
| 03/30/2011 | EP2300494A1 Anti-amyloid immunogenic compositions, methods and uses |
| 03/30/2011 | EP2300493A2 Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles |
| 03/30/2011 | EP2300492A1 A novel antiviral peptide against avian influenza virus h9n2 |
| 03/30/2011 | EP2300102A2 Long term disease modification using immunostimulatory oligonucleotides |
| 03/30/2011 | EP2300055A1 Anticancer combination therapy including triciribine |
| 03/30/2011 | EP2300053A1 Vaccines for prevention and treatment of addiction |
| 03/30/2011 | EP2300052A1 Novel synergistic effects |
| 03/30/2011 | EP2300051A1 Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis |
| 03/30/2011 | EP2300050A1 Vaccine for the treatment of alzheimer's disease |
| 03/30/2011 | EP2300040A2 Methods and compositions for prostate cancer immunotherapy |
| 03/30/2011 | EP2300022A2 Regulatory b cells and their uses |
| 03/30/2011 | EP2027156B9 Hepatocyte growth factor (hgf) binding proteins |
| 03/30/2011 | EP1861424B1 Human monoclonal antibodies against hendra and nipah viruses |
| 03/30/2011 | EP1843789B1 Compositions and methods for treating fibrotic disorders |
| 03/30/2011 | EP1799814B1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 03/30/2011 | EP1641488B1 Epitope composition for enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin |
| 03/30/2011 | EP1592443B1 Improved anthrax vaccines and delivery methods |
| 03/30/2011 | EP1572233B1 Use of HPV16 and HPV18 as vaccine against one or more of oncogenic HPV type 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 |
| 03/30/2011 | EP1426764B1 Method of diagnosing or monitoring saccharometabolic error |
| 03/30/2011 | EP1394261B1 Antigens for immunisation |
| 03/30/2011 | EP1361890B1 Influenza vaccine formulations for intradermal delivery |
| 03/30/2011 | EP1355658B1 Anti HER3 antibody for diagnosis, prevention and treatment of hyperproliferative diseases |
| 03/30/2011 | EP1317485B1 Myostatin antagonists and uses thereof |
| 03/30/2011 | CN1984620B Bioactive bracket for type II diabetics |
| 03/30/2011 | CN1956995B Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same |
| 03/30/2011 | CN101998992A Methods involving MS4A12 and agents targeting MS4A12 for therapy, diagnosis and testing |
| 03/30/2011 | CN101998990A Improvements in preparation of influenza virus vaccine antigens |
| 03/30/2011 | CN101998987A Commensal bacteria as signal mediators within a mammalian host |
| 03/30/2011 | CN101998864A 调节t细胞依赖性免疫应答的方法 The method of regulating cell-dependent immune response t |
| 03/30/2011 | CN101998863A Use of anti-amyloid beta antibody in ocular diseases |
| 03/30/2011 | CN101993888A Method for producing and recombining main allergic protein Hum j 3 of Humulus scandens by induced secretion expression |
| 03/30/2011 | CN101993498A Adenovirus vector avian influenza recombinant vaccine |
| 03/30/2011 | CN101993493A Anti-tumor monoclonal antibody and preparation method and application thereof |
| 03/30/2011 | CN101993492A ScFv antibody for resisting H5N1 type highly-pathogenic avian influenza and application thereof |
| 03/30/2011 | CN101993478A Multi-epitope recombinant protein of epstein-barr (EB) virus latent membrane protein 2 and application thereof |
| 03/30/2011 | CN101991864A Leptospira interrogans DNA (Deoxyribose Nucleic Acid) vaccine as well as construction method and application thereof |
| 03/30/2011 | CN101991863A Double-target DNA vaccine and constructing method thereof |
| 03/30/2011 | CN101991850A Preparation technology of nanometer aluminum hydroxide adjuvant |
| 03/30/2011 | CN101991849A Preparation method of swine pseudorabies vaccine |
| 03/30/2011 | CN101991848A Synthetic peptide vaccine for swine fever and application thereof |
| 03/30/2011 | CN101991847A Triple inactivated vaccine against dairy cattle mastitis and preparation method thereof |
| 03/30/2011 | CN101991846A Inactivated vaccine for Escherichia coli mastitis of dairy cow and preparation method thereof |
| 03/30/2011 | CN101991845A Duck infectious serositis inactivated vaccine emulsification method |
| 03/30/2011 | CN101991844A Edwardsiella tarda recombinant subunit vaccine and application thereof |
| 03/30/2011 | CN101991843A Multiple antigen peptide (MAP) vaccine and application thereof |
| 03/30/2011 | CN101575589B Abortus Brucella vaccine strain S19 marked recombinant strain and application thereof |
| 03/30/2011 | CN101503686B DNA sequence for reinforcing bacterial virus bacteriolysis gene perforating efficiency and use thereof |
| 03/30/2011 | CN101294162B P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 03/30/2011 | CN101259269B Freeze-drying hepatitis A varicella attenuation combined vaccine and producing method thereof |
| 03/30/2011 | CN101085811B SARS coronavirus pharmaceutical target and application thereof |
| 03/29/2011 | US7915396 Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49 |
| 03/29/2011 | US7915393 Compositions and methods for WT1 specific immunotherapy |
| 03/29/2011 | US7915381 Immunomodulatory flagellin peptide having at least about 10 amino acids; immunotherapy treatment of cancer |
| 03/29/2011 | US7915226 Methods of suppressing microglial activation |
| 03/29/2011 | US7915009 Modulating NF-kappa B by administering antigens or polynucleotide encoding antigens, antibody; treating cancer, tumor, Alzheimer's disease or a spongiform encephalopathy; DNA vaccine in kits |
| 03/29/2011 | US7914802 Mucosal vaccine adjuvants containing bacterial flagellins as an active component |
| 03/29/2011 | US7914800 LTB4 as vaccine adjuvant |
| 03/29/2011 | US7914799 Anti-fungal composition |
| 03/29/2011 | US7914798 Compositions and methods of use of ORF1358 from beta-hemolytic streptococcal strains |
| 03/29/2011 | US7914797 Influenza vaccine |
| 03/29/2011 | US7914796 Engineered cleavage half-domains |
| 03/29/2011 | US7914795 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 03/29/2011 | US7914794 Protein vaccine; culture product; genetic engineering |
| 03/29/2011 | US7914793 Method for producing an antigenic substance and antibody |
| 03/29/2011 | US7914792 Methods and compounds for raising antibodies and for screening antibody repertoires |
| 03/29/2011 | US7914791 Vaccine |
| 03/29/2011 | US7914790 Human IgM antibody lysing activated lymphocytes under mediation by homologous complement |
| 03/29/2011 | US7914789 HEMCM42 antibodies |
| 03/29/2011 | US7914788 Monoclonal antibodies against orthopoxviruses |
| 03/29/2011 | US7914787 Provide inter alia a bi-specific antibody or antibody fragment having one arm that specifically binds a targeted tissue and one other arm that specifically binds a targetable conjugate that can be modified for use in a wide variety of diagnostic and therapeutic applications |
| 03/29/2011 | US7914786 Compositions and methods for treating kidney disease |
| 03/29/2011 | US7914785 B-cell depleting agents, like anti-CD20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome |
| 03/29/2011 | US7914784 Insulin-like growth factor I receptor (IGF-IR) specific monoclonal antibodies for diagnosis, prevention and treatment of cell proliferative disorders |
| 03/29/2011 | US7914778 Methods of treatment using IL-16 antagonist peptides |
| 03/29/2011 | CA2617341C Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus |
| 03/29/2011 | CA2522378C Method of detecting probnp with a monoclonal antibody binding to the amino acids 41-46 |
| 03/29/2011 | CA2448083C Liquid preparations of fudosteine |
| 03/29/2011 | CA2446327C A polypeptide and dna thereof useful as a neovascular marker |
| 03/29/2011 | CA2418784C Use of compounds derived from the genus euphorbia for the treatment of carcinoma of the bladder |
| 03/29/2011 | CA2392653C Production of vaccines |
| 03/29/2011 | CA2390652C Human circulating virus-inhibiting peptide (virip) and its use |
| 03/29/2011 | CA2345276C Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 03/29/2011 | CA2256306C Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 03/29/2011 | CA2252438C Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| 03/29/2011 | CA2239151C Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 03/29/2011 | CA2228128C Method for industrially producing a japanese encephalitis vaccine, and resulting vaccine |
| 03/29/2011 | CA2207815C Modulators of the function of fas/apo1 receptors |
| 03/29/2011 | CA2174354C Compositions of melanoma differentiation associated gene-7 (mda-7) in cancer diagnosis and treatment |